<!DOCTYPE html>
<html lang="en">
<head>
  <meta charset="UTF-8">
  <title>Toxins and Antidotes: Emergency Department Management</title>
  <meta name="viewport" content="width=device-width, initial-scale=1.0">

  <link rel="stylesheet" href="/genralPages.css">
  <script src="/script.js"></script>
  <script src="https://kit.fontawesome.com/834304401a.js" crossorigin="anonymous"></script>

  <style>
    body {
      font-family: 'Helvetica Neue', Helvetica, Arial, sans-serif;
      font-size: 16px;
      font-weight: bold;
      line-height: 1.8;
      color: #333;
      margin: 0;
      background-image: url("/adultresus/images/toxins.jpg");
      background-size: cover;
      background-repeat: no-repeat;
      background-position: center;
    }

    main {
      padding: 1rem;
      max-width: 900px;
      margin: 0 auto 2rem auto;
    }

    .section-card {
      background: rgba(255, 255, 255, 0.96);
      border-radius: 12px;
      padding: 1rem 1.25rem;
      margin-bottom: 1rem;
      box-shadow: 0 2px 6px rgba(0, 0, 0, 0.08);
    }

    .page-title {
      font-size: 1.5rem;
      margin: 0 0 0.4rem 0;
      color: #003366;
      text-align: center;
    }

    .page-subtitle {
      font-size: 0.9rem;
      text-align: center;
      color: #555;
      margin-bottom: 0.75rem;
    }

    h2 {
      font-size: 1.1rem;
      margin-top: 0;
      margin-bottom: 0.5rem;
      color: #0066cc;
    }

    h3 {
      font-size: 1rem;
      margin-top: 0.5rem;
      margin-bottom: 0.3rem;
      color: #004c99;
    }

    p {
      margin: 0.3rem 0;
      font-size: 0.9rem;
      line-height: 1.5;
      font-weight: normal;
    }

    ul, ol {
      margin: 0.4rem 0;
      padding-left: 1.3rem;
      font-weight: normal;
    }

    li {
      margin-bottom: 0.25rem;
      font-size: 0.9rem;
    }

    .pill-note {
      display: inline-block;
      background: #e6f2ff;
      color: #003366;
      padding: 0.25rem 0.6rem;
      border-radius: 999px;
      font-size: 0.8rem;
      margin-bottom: 0.5rem;
    }

    .note-text {
      font-size: 0.8rem;
      color: #666;
      font-style: italic;
      margin-top: 0.3rem;
    }

    .danger-box {
      background-color: #fff5f5;
      border-left: 4px solid #cc0000;
      padding: 10px 12px;
      margin-top: 0.4rem;
      border-radius: 6px;
      font-size: 0.9rem;
    }

    .danger-box ul {
      margin-top: 0.3rem;
    }

    .red-flag {
      font-weight: 600;
      color: #b22222;
    }

    /* Table */
    .table-wrapper {
      width: 100%;
      overflow-x: auto;
      margin-top: 0.3rem;
    }

    table {
      border-collapse: collapse;
      width: 100%;
      min-width: 360px;
      font-size: 0.85rem;
    }

    th, td {
      padding: 8px 10px;
      text-align: left;
      border-bottom: 1px solid #ccc;
      vertical-align: top;
      font-weight: normal;
    }

    th {
      background-color: #f2f2f2;
      color: #003366;
      font-weight: 600;
      white-space: nowrap;
    }

    /* QUICK LINKS STRIP */
    .quick-links-strip {
      display: flex;
      flex-wrap: wrap;
      gap: 0.5rem;
      margin-top: 0.6rem;
    }

    .quick-link-btn {
      flex: 1 1 46%;
      min-width: 130px;
      text-align: center;
      text-decoration: none;
      padding: 0.4rem 0.5rem;
      border-radius: 999px;
      border: 1px solid #c5d7f2;
      background: #e9f1ff;
      font-size: 0.85rem;
      color: #003366;
      display: inline-flex;
      align-items: center;
      justify-content: center;
      gap: 0.35rem;
    }

    .quick-link-btn i {
      font-size: 0.85rem;
      opacity: 0.8;
    }

    .quick-link-btn:hover,
    .quick-link-btn:focus {
      background: #d7e6ff;
    }

    @media (max-width: 600px) {
      main {
        padding: 0.75rem;
      }

      .section-card {
        padding: 0.8rem 0.85rem;
      }

      .page-title {
        font-size: 1.3rem;
      }

      th, td {
        padding: 7px;
      }
    }
  </style>
</head>
<body>
<header>
  <nav class="logo-container">
    <div class="logo-container">
      <h1 class="main-header">Toxins and Antidotes: ED Management</h1>
      <div class="navbar-icons">
        <a href="/index.html" title="Home"><i class="fa-solid fa-house" alt="House icon"></i></a>
      </div>
      <button class="back-button" onclick="goBack()">Back</button>
    </div>
  </nav>
</header>

<main>

  <!-- INTRO -->
  <section class="section-card">
    <h2 class="page-title">Toxins &amp; Antidotes – ED Guide</h2>
    <p class="page-subtitle">
      Use this as a bedside framework. Always combine with your local toxicology protocols and senior input.
    </p>
    <span class="pill-note">Senior approach</span>
    <p class="note-text">
      Aim to stabilise first (ABCDE), then identify toxidrome &amp; likely agent, then decide whether a specific antidote will
      meaningfully change outcome.
    </p>

    <!-- QUICK LINK STRIP -->
    <div class="quick-links-strip">
      <a href="/adultresus/hyperkalaemia.html" class="quick-link-btn">
        <i class="fa-solid fa-bolt"></i>
        Hyperkalaemia Emergency
      </a>
      <a href="/adultresus/antidoteQuickRef.html#hiet" class="quick-link-btn">
        <i class="fa-solid fa-syringe"></i>
        HIET Quick Dosing
      </a>
      <a href="/adultresus/antidoteQuickRef.html#lipid" class="quick-link-btn">
        <i class="fa-solid fa-oil-can"></i>
        Intralipid Rescue
      </a>
      <a href="/adultresus/antidoteQuickRef.html" class="quick-link-btn">
        <i class="fa-solid fa-table-list"></i>
        Antidote Dosing Table
      </a>
    </div>
  </section>

  <!-- INITIAL ED APPROACH -->
  <section class="section-card">
    <h2>1. Initial ED Approach to Suspected Poisoning</h2>
    <ol>
      <li><strong>Stabilise – ABCDE</strong>
        <ul>
          <li>Airway: protect early if reduced GCS, seizures, or risk of aspiration.</li>
          <li>Breathing: oxygen, support ventilation; beware respiratory depression (opioids, benzos, sedatives).</li>
          <li>Circulation: IV access, fluids as needed, monitor BP, HR, rhythm.</li>
          <li>Disability: GCS, pupils, capillary glucose (hypoglycaemia can mimic overdose).</li>
          <li>Exposure: temperature, check for patches, injection sites, containers in pockets/bag.</li>
        </ul>
      </li>

      <li><strong>Decontamination (only if safe &amp; appropriate)</strong>
        <ul>
          <li>Remove contaminated clothing, wash exposed skin/eyes with copious water.</li>
          <li>Activated charcoal: only under senior/toxicology guidance (usually within 1 hour, protected airway).</li>
        </ul>
      </li>

      <li><strong>Look for a toxidrome</strong>
        <ul>
          <li>Opioid: CNS depression, pin-point pupils, hypoventilation.</li>
          <li>Sympathomimetic: agitation, tachycardia, hypertension, dilated pupils, sweating.</li>
          <li>Anticholinergic: tachycardia, hyperthermia, dry skin, dilated pupils, urinary retention, delirium.</li>
          <li>Cholinergic (organophosphates): SLUDGE/DUMBELS, bronchorrhoea, bronchospasm.</li>
        </ul>
      </li>

      <li><strong>Early investigations</strong>
        <ul>
          <li>VBG/ABG, U&amp;E, LFTs, glucose, FBC, ECG.</li>
          <li>Drug-specific levels where relevant &amp; available (e.g. paracetamol).</li>
        </ul>
      </li>
    </ol>

    <div class="danger-box">
      <strong>Red flags – call senior/toxicology and consider ICU:</strong>
      <ul>
        <li class="red-flag">Airway compromise or persistent hypoxia</li>
        <li class="red-flag">Shock, arrhythmia, or significant ECG changes</li>
        <li class="red-flag">Recurrent seizures or reduced GCS not improving</li>
        <li class="red-flag">Severe metabolic acidosis or rising lactate</li>
        <li class="red-flag">Suspected massive ingestion of cardiotoxic drugs (e.g. TCAs, beta-blockers, CCBs)</li>
      </ul>
    </div>
  </section>

  <!-- COMMON TOXINS TABLE -->
  <section class="section-card">
    <h2>2. Common Toxins and Their Antidotes</h2>
    <p class="note-text">
      This table highlights key ED toxins. Always confirm doses with local protocol / toxicology service.
    </p>

    <div class="table-wrapper">
      <table>
        <thead>
        <tr>
          <th>Toxin / Group</th>
          <th>Key Features</th>
          <th>Antidote / Key Therapy</th>
        </tr>
        </thead>
        <tbody>
        <tr>
          <td>Paracetamol (Acetaminophen)</td>
          <td>Nausea, vomiting, RUQ pain; initially well then hepatic failure 24–72 h later.</td>
          <td>
            <strong>N-acetylcysteine (NAC)</strong> – start early, do not wait for LFT derangement. Use nomogram if time of ingestion known.
          </td>
        </tr>
        <tr>
          <td>Aspirin / Salicylates</td>
          <td>Tinnitus, vomiting, tachypnoea, metabolic acidosis, mixed respiratory alkalosis.</td>
          <td>
            <strong>Sodium bicarbonate</strong> infusion (alkalinise serum &amp; urine), activated charcoal (if appropriate), <strong>haemodialysis</strong> in severe cases.
          </td>
        </tr>
        <tr>
          <td>Opioids</td>
          <td>CNS depression, pin-point pupils, hypoventilation, bradycardia.</td>
          <td>
            <strong>Naloxone</strong> IV/IM/IN – titrate to adequate ventilation, not full arousal. Beware short half-life vs long-acting opioids.
          </td>
        </tr>
        <tr>
          <td>Benzodiazepines</td>
          <td>Drowsiness, ataxia, respiratory depression (especially with co-ingestants).</td>
          <td>
            Supportive care, airway protection as needed.<br>
            <strong>Flumazenil is generally avoided</strong> in mixed overdoses or chronic users due to seizure risk – specialist decision only.
          </td>
        </tr>
        <tr>
          <td>Tricyclic antidepressants (TCAs)</td>
          <td>Confusion, seizures, hypotension, wide QRS, arrhythmias.</td>
          <td>
            <strong>Sodium bicarbonate</strong> boluses/infusion for QRS widening/hypotension; early intubation in severe cases, continuous ECG monitoring.
          </td>
        </tr>
        <tr>
          <td>Organophosphates / Carbamates</td>
          <td>Cholinergic toxidrome: salivation, lacrimation, urination, diarrhoea, vomiting, bronchorrhoea, bronchospasm, bradycardia.</td>
          <td>
            <strong>Atropine</strong> (large, repeated doses) for secretions &amp; bronchospasm;<br>
            <strong>Oximes</strong> (e.g. pralidoxime) if available and indicated; early airway control.
          </td>
        </tr>
        <tr>
          <td>Carbon Monoxide</td>
          <td>Headache, nausea, dizziness, confusion, collapse; normal SpO₂ on pulse oximetry.</td>
          <td>
            <strong>High-flow oxygen</strong> (non-rebreather); consider <strong>hyperbaric oxygen</strong> in selected severe cases according to protocol.
          </td>
        </tr>
        <tr>
          <td>Cyanide</td>
          <td>Rapid collapse, seizures, lactic acidosis, cardiovascular collapse (often in fire victims or industrial exposures).</td>
          <td>
            <strong>Hydroxocobalamin</strong> (if available) or cyanide antidote kit (e.g. nitrites + thiosulfate) as per local guidelines, plus aggressive supportive care.
          </td>
        </tr>
        <tr>
          <td>Lead &amp; Heavy metals</td>
          <td>Abdominal pain, neuropathy, anaemia, encephalopathy (chronic exposures).</td>
          <td>
            Chelation therapy: <strong>Dimercaprol (BAL)</strong>, EDTA, or <strong>succimer</strong> – specialist/toxicology guided.
          </td>
        </tr>
        <tr>
          <td>Beta-blockers</td>
          <td>Bradycardia, hypotension, hypoglycaemia, shock.</td>
          <td>
            Supportive care, atropine, fluids; consider <strong>glucagon</strong>, high-dose insulin euglycaemic therapy (HIET) per protocol, vasopressors; early senior input.
          </td>
        </tr>
        <tr>
          <td>Calcium Channel Blockers</td>
          <td>Hypotension, bradycardia, hyperglycaemia, shock.</td>
          <td>
            <strong>Calcium</strong> (chloride/gluconate), HIET, vasopressors, lipid emulsion in selected cases – ICU-level management.
          </td>
        </tr>
        </tbody>
      </table>
    </div>
  </section>

  <!-- GENERAL ED MANAGEMENT SUMMARY -->
  <section class="section-card">
    <h2>3. General ED Management Principles</h2>
    <ul>
      <li>Take a focused history: time and amount of ingestion, co-ingestants, intent (accidental vs deliberate self-harm), past medical history and meds.</li>
      <li>Search for evidence: pill bottles, blister packs, chemical containers, family/witness information.</li>
      <li>Provide supportive care: oxygen, IV fluids, temperature control, seizure control, anti-emetics.</li>
      <li>Repeat clinical assessment frequently – many overdoses evolve over hours.</li>
      <li>Safety first: protect staff from contaminated patients (PPE, decontamination area where possible).</li>
    </ul>

    <p class="note-text">
      Senior tip: antidotes are powerful but limited – most toxicology is supportive care, good observation, and early recognition of deterioration.
    </p>
  </section>

  <!-- PROTOCOLS LINK -->
  <section class="section-card">
    <h2>Toxicology Protocols</h2>
    <p>
      For detailed dosing, infusion regimes, and local pathways, refer to your hospital / provincial protocols:
    </p>
    <p>
      <a href="/pdfs/tox_protocols.pdf" target="_blank" class="emphasis-link">
        View Toxicology Protocols (PDF)
      </a>
    </p>
  </section>

</main>
</body>
</html>
